Screener
Aligos Therapeutics, Inc. ALGS Q1 2025 earnings
Reported May 6, 2025 · Before market open
Revenue$311.0KMiss by $189.0K
EPS-$2.11Beat by $0.69
Revenue estimate$500.0K
EPS estimate-$2.80
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$4.9M
EPS estimate-$2.44
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Aligos Therapeutics, Inc. report Q1 2025 earnings?
- Aligos Therapeutics, Inc. (ALGS) reported Q1 2025 earnings on May 6, 2025 before market open.
- What were Aligos Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- Aligos Therapeutics, Inc. reported revenue of $311.0K and eps of $-2.11 for Q1 2025.
- Did Aligos Therapeutics, Inc. beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $500.0K by $189.0K. EPS beat the consensus estimate of $-2.80 by $0.69.
- How did Aligos Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 68.5% from $986.0K a year earlier and eps grew 61.6% from $-5.50.
- Where can I find Aligos Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001171843-25-002781) and the 10-Q periodic report (0000950170-25-063983) directly on SEC EDGAR. The filing index links above go to sec.gov.
